Moneycontrol PRO


Bull vs Bear: What's the outlook on Sun Pharma?

Sun Pharma is the biggest loser on the Nifty as it missed estimates. Also, the management gave a very conservative guidance of 8-10 percent growth in consolidated sales for FY17. A bullish SP Tulsian of gave a support price of Rs 700.

first published: May 31, 2016 03:47 pm


Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows